Abstract:Introduction Dilated cardiomyopathy (DCM) exhibits an annual incidence of 5-7 cases per 100,000 persons and a worldwide prevalence of 1:2500 individuals, with a genetic involvement in 35% of all cases (TTN and LMNA gene mutation accounting for the majority). Amongst the numerous genetic mutations, prior research has linked PTPN11 gene mutations to hypertrophic cardiomyopathy. Our case sheds light on the association between PTPN11 mutation and the development of isolated DCM. Case A 54-year-old lady with no remarkable medical history presented with typical symptoms of heart failure. CT coronary angiography revealed normal coronary arteries, and echocardiography (fig.1) demonstrated a left ventricular ejection fraction of 40%, with an indexed left ventricular end-diastolic volume (LVEDVi) of 79 ml/m2, suggestive of moderate-severe dilation. The patient also had a family history of non-ischemic heart failure with reduced ejection fraction (HFrEF) in her younger sister at the age of 45, reportedly due to stress but with no extensive workup. Stemming from the patient's refusal to undergo cardiac MRI, genetic testing was pursued, and she underwent whole genome testing which identified a missense mutation in coding exon 7 of the PTPN11 gene. Discussion PTPN11 is a gene that produces SHP2, a tyrosine phosphatase (PTP) protein. A gain of function mutation in PTPN11 is responsible for approximately 50% of cases of Noonan syndrome (NS). Although NS is commonly associated with hypertrophic cardiomyopathy (HCM) that leads to heart failure with preserved ejection fraction (HFpEF), the prevalence of HCM is low in individuals with NS caused by PTPN11 mutation. Conversely, DCM, which leads to HFrEF, has been rarely reported in NS, with only two documented cases in literature, albeit correlation with PTPN11 was not specified. Murine studies suggested that a deletion mutation in PTPN11 leads to abnormal activation of the Erk/MAPK protein and RhoA signaling pathways, resulting in rapid DCM development. Additionally, missense defects in PTPN11 were found to lead to prolonged phosphatase activity, mutations of which (mainly PP1 and PP2A, reportedly present in human hearts) also lead to DCM. Our patient was found to carry a specific PTPN11 mutation: c.794G>T(p.Arg265Leu), which is inherited in an autosomal dominant manner. Given that she had no predisposing factors for DCM, it is speculated that this PTPN11 variant may be an independent risk factor for isolated DCM induced HFrEF. Further clinical correlation and familial testing are required to fully understand the effect of this variant on the heart, which could have significant implications for both diagnosis and treatment of this debilitating cardiovascular disorder.

Phospholamban Cardiomyopathy Leading to Advanced Heart Failure in an Active Duty Service Member

Nuclear envelope lamin-related dilated cardiomyopathy: a case series including histopathology

A case report of a rare genetic mutation (LMNA-C.185G>C, p.Arg62Pro) associated with dilated cardiomyopathy in a Han Chinese child

Familial dilated cardiomyopathy in a child: a case report

Identification of a LMNA (c.646c > T) Variant by Whole-Exome Sequencing in Combination with a Dilated Cardiomyopathy (DCM) Related Gene Filter in a Family with Familiar DCM

Genetic Mutation of Familial Dilated Cardiomyopathy Based on Next‑generation Semiconductor Sequencing.

Cardiomyopathy with an LMNA Genetic Variant Affecting Three Consecutive Generations: A Case Series

Case Report: A novel desmoplakin mutation in a taiwanese woman with familial dilated cardiomyopathy that necessitated heart transplantation

Next-generation Sequencing Identified Novel Desmoplakin Frame-Shift Variant in Patients with Arrhythmogenic Cardiomyopathy

Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy

Phospholamban p.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review

The Pathogenic Mechanisms of and Novel Therapies for Lamin A/C-Related Dilated Cardiomyopathy Based on Patient-Specific Pluripotent Stem Cell Platforms and Animal Models

Structures of PKA–phospholamban complexes reveal a mechanism of familial dilated cardiomyopathy

Case Report: An Atypical Form of Familial Partial Lipodystrophy Type 2 Due to Mutation in the Rod Domain of Lamin A/C

Impaired Cardiomyocyte Maturation Leading to DCM: A Case Report and Literature Review.

Pediatric dilated cardiomyopathy: a review of current clinical approaches and pathogenesis

The phenotypic characteristic observed by cardiac magnetic resonance in a PLN-R14del family

A 17-year-old Male with Duchenne muscular dystrophy complicated with dilated cardiomyopathy and large left ventricular mural thrombosis

PTPN11 Mutation, A Heartbreaking Revelation

Diagnosis and management of arrhythmogenic cardiomyopathy: a case report

Duchenne Muscular Dystrophy and Dilated Cardiomyopathy with Deletion of Exon 45 and 49